Everolimus Based Immunosuppression in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 24 Month Results from a Randomized Controlled Trial.

被引：0
|
作者：
Saliba, F. [1 ]
Brown, R. S., Jr. [1 ]
Metselaar, H. [1 ]
Beckebaum, S. [1 ]
Duvoux, C. [1 ]
Navasa, M. [1 ]
Dong, G. [2 ]
Lopez, P. [3 ]
Nevens, F. [1 ]
机构：
[1] H2304 Study Grp, Villejuif, France
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Novartis Pharma AG, Basel, Switzerland
来源：
LIVER TRANSPLANTATION | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S100 / S101
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials
    Lee, Sung-Gyu
    Jeng, Long-Bin
    Saliba, Faouzi
    Soin, Arvinder Singh
    Lee, Wei-Chen
    De Simone, Paolo
    Nevens, Frederik
    Suh, Kyung-Suk
    Fischer, Lutz
    Joo, Dong Jin
    Fung, John
    Joh, Jae-Won
    Kaido, Toshimi
    Grant, David
    Meier, Matthias
    Rauer, Barbara
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    TRANSPLANTATION, 2021, 105 (07) : 1564 - 1575
  • [22] Everolimus-Facilitated Reduction Of Tacrolimus Provides Comparable Efficacy And Superior Renal Function Versus Standard Tacrolimus In De Novo Liver Transplant Recipients: 24-Month Results Of A Randomized Trial
    Saliba, Faouzi
    De Simone, Paolo
    Nevens, Frederik
    De Carlis, Luciano
    Metselaar, Herold
    Beckebaum, Susanne
    Jonas, Sven
    Sudan, Debra
    Fischer, Lutz
    Fung, John J.
    Dong, Gaohong
    Lopez, Patricia M.
    Junge, Guido
    HEPATOLOGY, 2012, 56 (06) : 1519 - 1519
  • [23] Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12-and 36-month results
    Levy, Gary
    Schmidli, Heinz
    Punch, Jeffrey
    Tuttle-Newhall, Elizabeth
    Mayer, David
    Neuhaus, Peter
    Samuel, Didier
    Nashan, Bjorn
    Klempnauer, Juergen
    Langnas, Alan
    Calmus, Yvon
    Rogiers, Xavier
    Abecassis, Michael
    Freeman, Richard
    Sloof, Maarten
    Roberts, John
    Fischer, Lutz
    LIVER TRANSPLANTATION, 2006, 12 (11) : 1640 - +
  • [24] 24 month safety results of a randomized, multicenter, double-blind study of everolimus vs azathioprine in de novo heart transplant recipients.
    Eisen, H
    Kobashigawa, J
    Starling, RC
    Cretin, N
    Jaffe, J
    Murphy, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 282 - 283
  • [25] Everolimus facilitated reduction of tacrolimus in de novo liver transplant recipients (LTxR): 12-24 month data from North America
    Chapman, W. C.
    Brown, R. S., Jr.
    Sudan, D.
    Chavin, K. D.
    Koneru, B.
    Huang, M. A.
    Junge, G.
    Hexham, J. M.
    Dong, G.
    Wiland, A.
    Patel, D.
    Fung, J.
    PHARMACOTHERAPY, 2013, 33 (10): : E237 - E238
  • [26] Everolimus Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients: 12-24 Month Data from North America.
    Chapman, W.
    Brown, R., Jr.
    Sudan, D.
    Chavin, K.
    Koneru, B.
    Huang, M.
    Junge, G.
    Hexham, J.
    Dong, G.
    Wiland, A.
    Fung, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 506 - 507
  • [27] Exposure-Response Analysis of Everolimus and Tacrolimus in De Novo Liver Transplant Recipients: 24-Month Results from the H2304 Study.
    Fischer, L.
    Kaiser, G. M.
    Huang, M. A.
    Toselli, L.
    Durand, F.
    Heaton, N.
    Shetty, K.
    Klintmalm, G.
    Dong, G.
    Lopez, P.
    Junge, G.
    Kovarik, J. M.
    LIVER TRANSPLANTATION, 2013, 19 : S148 - S148
  • [28] Incidence of CMV infection with concentration-controlled everolimus or MMF:: 12-month results from a randomized trial in de novo heart transplant patients
    Pellegrini, Carlo
    Dengler, Thomas
    Branzi, Angelo
    Guillemain, Romain
    Varnous, Shaida
    Gerosa, Gino
    Poncelet, Alain
    Vanhaecke, Johan
    Li, Yulan
    Gezahegen, Yonas
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 571 - 571
  • [29] Efficacy and safety of everolimus in combination with reduced tacrolimus in de novo liver transplant recipients: 36-month results from the randomized H2304 study
    Saliba, Faouzi
    Kaiser, Gernot M.
    De Carlis, Luciano
    Metselaar, Herold J.
    De Simone, Paolo
    Duvoux, Christophe
    Nevens, Frederik
    Fischer, Lutz
    Fung, John J.
    Dong, Gaohong
    Rauer, Barbara
    Junge, Guido
    HEPATOLOGY, 2013, 58 (06) : 1383A - 1383A
  • [30] EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY
    Saliba, F.
    Duvoux, C.
    Durand, F.
    Neau-Cransac, M.
    Hardwigsen, J.
    Pageaux, G.
    Di Giambattista, F.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 18 - 18
12345